Advertisement

Topics

#news #biotech Genentech pays Xencor $120M for rights to IL-15 cancer pipeline

10:11 EST 6 Feb 2019 | Biotech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Genentech pays Xencor $120M for rights to IL-15 cancer pipeline .Genentech has paid $120 million upfront to secure global rights to IL-15 cytokine therapeutics in preclinical development at … Continue reading

Original Article: #news #biotech Genentech pays Xencor $120M for rights to IL-15 cancer pipeline

NEXT ARTICLE

More From BioPortfolio on "#news #biotech Genentech pays Xencor $120M for rights to IL-15 cancer pipeline"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...